chrisvoncsefalvay/vaers-outcomes huggingface dataset:
little headache; I could barely lift my left arm; could barely walk; arm swollen; brain fog like I was out of it; metal taste in mouth; whole body hurt; muscle ache; so tired; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (could barely walk), PERIPHERAL SWELLING (arm swollen), FEELING ABNORMAL (brain fog like I was out of it), DYSGEUSIA (metal taste in mouth) and PAIN (whole body hurt) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D2NA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Aug-2021, the patient experienced PAIN (whole body hurt), MYALGIA (muscle ache) and FATIGUE (so tired). On 12-Aug-2021, the patient experienced GAIT DISTURBANCE (could barely walk), PERIPHERAL SWELLING (arm swollen), FEELING ABNORMAL (brain fog like I was out of it), DYSGEUSIA (metal taste in mouth) and VACCINATION SITE PAIN (I could barely lift my left arm). On 13-Aug-2021, the patient experienced HEADACHE (little headache). At the time of the report, GAIT DISTURBANCE (could barely walk), PERIPHERAL SWELLING (arm swollen), FEELING ABNORMAL (brain fog like I was out of it), DYSGEUSIA (metal taste in mouth), PAIN (whole body hurt), VACCINATION SITE PAIN (I could barely lift my left arm), MYALGIA (muscle ache), HEADACHE (little headache) and FATIGUE (so tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Aug-2021, SARS-CoV-2 test: negative (Negative) COVID test negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by reporter. No treatment medication were provided by reporter. Patient felt stuck on left arm and chest. Patient felt better on 13-Aug-2021. The patient felt that whole body was hurt on 12-Aug-2021.   Reporter did not allow further contact
The night I received the vaccine I was awake at 3 am and felt the chills crawl from my toes to my forehead in which I had flu like symptoms (fever, chills, aches, intense headache) for the whole day the next day. Those symptoms subsided but I've felt very lethargic every day since and the passed few days I've been having chest pains and pressure near my heart.
temperature excursion with Pediarix vaccines on 04May2023 that lasted 45 minutes and reached a low temperature of -0.8C; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a 6-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 25L52, expiry date 28-MAR-2025) for prophylaxis.   On 05-MAY-2023, the patient received Pediarix. On an unknown date, an unknown time after receiving Pediarix, the patient experienced incorrect storage of drug (Verbatim: temperature excursion with Pediarix vaccines on 04May2023 that lasted 45 minutes and reached a low temperature of -0.8C). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 11-May-2023 The pharmacist reported that a clinic experienced a temperature excursion with Pediarix vaccines one day prior to the reporting date that lasted 45 minutes and reached a low temperature of minus 0.8 Celsius. At the time of reporting, the dose had not been repeated. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. The patient received a dose of Pediarix after temperature excursion, which led to incorrect storage of drug.
Started with a cough and ended up getting the flu shortly after the vaccine. Was not around anyone else with known symptoms. After all the recalls, safe to assume that it was from the nasal h1n1 vaccination. A month later, still battling a secondary infection of bronchitis. It would be nice if the government would actually come out and say that you can in fact get the flu from the vaccine if they vaccine isn't strong enough. This was straight from my doctor.
Pt experienced an inject site rxn which included induration (6 1/2cm) warm to the touch & tenderness; Tx included ANCEF followed w/Cephadroxil & Cipro;
About 4 hours after vaccination, I started with itchy eyes, then mild swelling of upper and lower eyelids, which lasted about 2 hours. I also experienced itching of head, face, neck, upper trunk and arms from about 1:30 pm, for 4 or 5 hours, without any visible rash.
patient reported skin condition flaring up causing a rash from wrist to neck, no anaphylaxis
Arm pain x 3 days; fever for 48 hours, muscle/body pain x 48 hours; fatigue x 48 hours; severe headache has been on and off every day since the day of the injection, now 8 days in a row.
It was discovered on 01/24/2023 that the clinic had been storing the ProQuad vaccine in the fridge instead of the freezer.  Patient that was identified as receiving a dose of ProQuad that was stored improperly.  Patient will be notified to come back to clinic for another ProQuad vaccine.  Patient had not contact clinic with any adverse reactions to initial dose given.
chest pain; dizziness; "feel like I am going to stop breathing"/short of breath/I can't breath; "I can't walk"; feel like I'm going to faint; I can't stand up; excruciating pain,intolerable pain; body pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN, DIZZINESS, DYSPNOEA, GAIT INABILITY, and PRESYNCOPE in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Head injury in October 2021 and COVID-19 in November 2020. Concurrent medical conditions included Atrial fibrillation, Heart murmur, Blood pressure high and Chest pain.   In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced CHEST PAIN, DIZZINESS, DYSPNOEA, GAIT INABILITY, PRESYNCOPE, MOBILITY DECREASED, PAIN, and MYALGIA. At the time of the report, CHEST PAIN, DIZZINESS, DYSPNOEA, and GAIT INABILITY had not resolved and PRESYNCOPE, MOBILITY DECREASED, PAIN, and MYALGIA outcome was unknown.            Treatment medications included Pain pill. Concomitant medications included Blood pressure medication, Water pill, and Something to go to the bathroom. Patient does not have history of myocarditis and pericarditis. Patient said that had chest pain normally but now has 3 times the usual chest pain. The symptoms started 1.5 hours after booster dose was given.   This case was linked to MOD-2021-048169 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes on 08-Nov-2021 the Follow up received on 08-Nov-2021 included addition of new events extreme side effects, body pain, I can't stand up, feel like I'm going to faint, excruciating pain, and intolerable pain.
Gave an adult dose HAVRIX to 18 year old patient. She reported being extremely sick later in the day. Became very nauseous and had the feeling like she was going to pass out. Her whole body became sore that evening and the next day. Patient was unable to attend work the day after vaccine was given. Patient stated that her anemia was controlled beforehand but now she's having difficulty keeping it managed. She did contact her doctor on 6/22/2018 to ask about the vaccine after we called her. They are going to do steroid shots for her immune system.
Pt says left axilla began to hurt the evening after his injection.  Came to clinic 2 days later.  Left axilla appears swollen.  Pt says it is tender to touch, hurts when he moves his arm.  Injection site appears normal.  Pt says the same thing happened after his HPV#2.  Says it was not as bad, and it got better in about one week.
Redness and swollen in area given lump under skin on right thigh. Advised to give warm compresses and Motrin.
spreading rash on both arms and both legs; tiny red dot with a darkish middle; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administration date 08Mar2021 20:00 (Lot number: ER8733) as dose 1, single and administration date 29Mar2021 18:00 (Lot number: 320308D) as dose 2, single for covid-19 immunisation. Relevant medical history included: "covid" (unspecified if ongoing), notes: If covid prior vaccination: Yes. There were no concomitant medications. The following information was reported: RASH (non-serious) with onset 30Mar2021 18:00, outcome "unknown", described as "spreading rash on both arms and both legs"; MACULE (non-serious) with onset 30Mar2021 18:00, outcome "unknown", described as "tiny red dot with a darkish middle". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rash, macule.  Additional information: Age at vaccination: 29 Years. Patient received 3rd dose of pfizer covid-19 vaccine on 01Nov2021, 10:00 AM, Lot number=EN6205, Vaccine location=Left arm for covid-19 immunisation. Adverse event: I have developed a spreading rash on both arms and both legs. They are tiny red dots with a darkish middle. They continue to spread across my body. If treatment ae: Antibiotic, Antiviral, Biopsy, Antiseptic, etc. patient was not covid tested post vaccination. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications in two weeks: None. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Follow-up attempts are completed. No further information is expected.
About 36 hours after my first dose, I woke up very thirsty and with "gummy," sticky eyes.  My moisture-producing glands, particularly my salivary glands were significantly affected and I had, in effect, (drug-induced?) Sjogrens Syndrome.  My salivary glands felt uncomfortable, perhaps because they were swollen. The symptoms have diminished somewhat in the past two weeks, but have not resolved.   I visited my PCP on  04/02/2021 and she advised to see her again if the symptoms did not continue to resolve on their own.  Note that in 2014, I had a similar, but more severe reaction to a single dose of Nitrofurantoin and regained nearly complete  salivary gland function after 9-12 months.
Information has been received from a physician concerning a 15 year old female with no pertinent medical history and history of drug reactions/allergies unspecified who on 19-FEB-2007 was vaccinated with first dose of Gardasil (lot # not reported) 0.5 IM. There was no concomitant medication. On 20-FEB-2007, the patient developed flu-like symptoms. The patient sought medical attention. The patient reported to the physician that she was experiencing a headache, not feeling well, and all over body pain (but not pain at the injection site). At the time of reporting, the outcome was unspecified. No further information was available at the time of reporting. Additional information has been requested. 07/06/07 This is in follow-up to report(s) previously submitted on 3/14/2007. Information has been received from a physician concerning a 15 year old female with no illness at the time of being vaccinated and no pertinent medical history and history of drug reactions/allergies who on 19-FEB-2007 was vaccinated with first dose of GARDASIL (lot # 656372/0243U) 0.5 ml IM in the left hip. There was no concomitant medication. On 20-FEB-2007, the patient developed flu-like symptoms. The patient sought medical attention. The patient reported to the physician that she was experiencing a headache, not feeling well, and all over body pain (but not pain at the injection site). At the time of reporting, the outcome was unspecified. No further information was available at the time of reporting. Additional information was received from the physician. On 19-FEB-2007, in the evening, the patient experienced pain at the injection site, associated hip and leg pain, mild swelling, headache, general malaise, and arthralgias. The events were reported as non-serious. On an unspecified date, the patient recovered. No additional information is expected.
Headache started 7 hours after getting the shot, followed by chills, fever of 101.3. Fever and chills lasted 12-14 hours. Headache is still lingering almost 48 hours later.
Burning Sensation Hip Replacement; Fatigue; Achy Joints; Headache; Muscle pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning Sensation Hip Replacement), FATIGUE (Fatigue), ARTHRALGIA (Achy Joints), HEADACHE (Headache) and MYALGIA (Muscle pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hip replacement (In 2019. Made of Titanium and Ceramic material.). Concurrent medical conditions included Allergy (Allergic to PCN). Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) and LOSARTAN for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced BURNING SENSATION (Burning Sensation Hip Replacement), FATIGUE (Fatigue), ARTHRALGIA (Achy Joints), HEADACHE (Headache), MYALGIA (Muscle pain) and NAUSEA (Nausea). On 18-Mar-2021, FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain) and NAUSEA (Nausea) had resolved. At the time of the report, BURNING SENSATION (Burning Sensation Hip Replacement) and ARTHRALGIA (Achy Joints) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication not reported.
pt recvd vax; t 102 w/ fever; aching joints; ankles were swollen; menstrual period started 2 wks earlier; was experiencing heavy flow at time of report;
This young lady did not meet age requirements to receive the Covid 19 vaccine from this Manufacturer, but was given it.
Rashes that turned into Burns and scabbed over I believe this is called shingles....?
BLEEDING; BODY PAIN/ EVERYTHING HURTS; BAD FEELING; HIGH FEVER (104F); This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 11:00 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On APR-2021, the subject experienced bleeding. On APR-2021, the subject experienced body pain/ everything hurts. On APR-2021, the subject experienced bad feeling. On APR-2021, the subject experienced high fever (104f).  Laboratory data included: Body temperature (NR: not provided) 104 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from high fever (104f), bleeding, and body pain/ everything hurts, and the outcome of bad feeling was not reported. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
24-48 he's post vaccine Acute Insomnia with severe anxiety component; 24-48 he's post vaccine Acute Insomnia with severe anxiety component/Anxiety worsening; Completely out of character with no preceding symptoms; very debilitated; This is a spontaneous report from a contactable physician (patient). A 52-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EH9899), via an unspecified route of administration, administered in left arm on 17Dec2020 8:00 as single dose, second dose via an unspecified route of administration, administered in left arm on 07Jan2021 (Batch/Lot Number: EL3246) as single dose for covid-19 immunisation. Medical history included hypertension and Increased cholesterol. Concomitant medication included atorvastatin (LIPITOR); lisinopril. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. other medications the patient received within 2 weeks of vaccination were Lipitor and Lisinopril. It was reported 24-48 hours post vaccine (18Dec2020 22:00) patient had Acute Insomnia with severe anxiety component. Completely out of character with no preceding symptoms. No prior history of any recent event to explain acute change in personality and character. Insomnia has now persisted for seven weeks. Was better two weeks after 1st dose then worsened again after the 2nd dose was given. Same timeline. Anxiety worsening. Never suffered form any psych issues. Highly functional Interventional Cardiologist now very debilitated. the adverse event result in doctor or other healthcare professional office/clinic visit; The patient received treatment with Psych therapy, Benzos, Ambien, Trazadone, Melatoni. Prior to vaccination, the patient not diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. The reported seriousness was non serious. The outcome of the events was not recovered.
S/S Itching, rash and warmth on neck chest and back. Time course: 2 hours 30 mins approx. Rx: OC Oral Benadryl and Epinephrine pen. Both Rx not used. Tx: n/a
patient received by error a third dose; This case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 73-year-old male patient who received Herpes zoster (Shingrix) (batch number 7GM34, expiry date 10th February 2023) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in February 2021) and Shingrix (received 2nd dose in May 2021).   On 10th October 2021, the patient received the 3rd dose of Shingrix. On 10th October 2021, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were provided as follows: The patient received by error a Shingrix third dose, which led to extra dose administered. The reporter consented to follow up.
Pt. c/o tenderness and edema, pain radiating from upper arm. Pain when moving arm in the upper area of arm. Pain to sleep on arm.
Within 8 hours pt experienced redness and swelling of left thigh (DTaP site), after 24 hours swelling increased to a 4" diameter, raised like a welt with redness. Advised to use ice and Benadryl.
dose administered to patient after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021 at 3:05 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Feb-2021 at 3:05 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was initially stored in the fridge on 09-Feb-2021, moved to clinic on 12-Feb-2021 and proposed beyond use date was 10-Mar-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit.  On the date of administration, at 09:00 A.M., the temperature recorded was 29 degree Fahrenheit, at 10:00 A.M., the temperature recorded was 35 degree Fahrenheit and at 11:00 A.M., the temperature recorded was 35 degree Fahrenheit that has been reached by the vial.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  The vial was not in a frozen state at the time of vaccine administration.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.   This case was linked to MOD-2022-566976 (Patient Link).
Vaccine reaction on (L) arm 3 1/2 in. x 3 1/2 in. Advised parent to use cold water, Tylenol
This case was reported by a nurse via call center representative and described the occurrence of therapy non-responder in an unspecified number of patients who received Hepatitis B vaccine. On an unknown date, the patient received Hepatitis B vaccine. On an unknown date, unknown after receiving Hepatitis B vaccine, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown. It was unknown if the reporter considered the therapy non-responder to be related to Hepatitis B vaccine. Additional details were provided as follows: The age at vaccination of the patients was not reported. The reporter stated that she worked for an infection control center. In the past there have been a number of new employees who stated that they received the entire Hepatitis-B series and afterward failed the titer. Thus, leading the patient to be a therapy non-responder. The reporter wanted to know if they needed to repeat the series. The reporter did not have the patient identifiers and was not sure if the Hepatitis-B was GlaxoSmithKline or not. No side effects were reported.
Pt recvd vax on 1JUN92 & 8JUN92 pt devel conjunctivitis, irritability & a temp of 104;
My right arm at injection site is swollen and hurts and my left side of my face is swollen.